Bard invests in urology ultrasound
Interventional equipment vendor C.R. Bard has invested $2 million for a minority equity interestin Diagnostic Ultrasound of Redmond, WA. Bard's patient care andurology divisions will also market Diagnostic Ultrasound's BladderScanBVI 2500 scanner in the
Interventional equipment vendor C.R. Bard has invested $2 million for a minority equity interestin Diagnostic Ultrasound of Redmond, WA. Bard's patient care andurology divisions will also market Diagnostic Ultrasound's BladderScanBVI 2500 scanner in the U.S.
BladderScan is a noninvasive, nonimaging ultrasound devicethat provides measurements of bladder volume. The measurementtechnique provides a lower cost and less risky alternative tourinary catheters often used for bladder diagnosis. Bard is amajor catheter supplier.
According to estimates from the Centers for Disease Control,the cost to the U.S. health-care system of hospital-induced infectionsamounts to over $2 billion annually. About 80% of these infectionsare induced during urinary catheterization.
Diagnostic Ultrasound expects sales to double this year, aidedby Bard's investment, the Bard marketing agreement, an equivalentinvestment by another unnamed source, and expanded internationalbusiness. The company's other product is Versadopp 10, a pen-sizedDoppler blood-flow sensor used to evaluate the risk of strokeor peripheral artery disease and to assist in surgery.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What New Research Reveals About Novice Use of AI-Guided Cardiac Ultrasound
April 4th 2025In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
